Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs

We investigated the cases who were positive both HBsAg and anti-HBs in the sera clinically and immunologically. 1) 36 cases in 191 HBsAg positive subjects (18.8%) had anti-HBs in the sera simultaneously, although the anti-HBs of those were not detected by passive hemmaglutination method. 2) In HBs-A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nippon Shokakibyo Gakkai Zasshi 1988, Vol.85(2), pp.186-192
Hauptverfasser: TAKAGI, Hitoshi, YAMADA, Shoji, HAYAKAWA, Kiyoya, OZAWA, Masako, OJIMA, Toru, TAKAYAMA, Hisashi, SAITOH, Shuuichi, UEHARA, Masahiro, ABE, Takehiko, IIZUKA, Harutarou, KATAKAI, Shigeyuki, ICHIKAWA, Kunio, TAKEZAWA, Jirou, NAGAMINE, Takeaki, KOBAYASHI, Setsuo
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 192
container_issue 2
container_start_page 186
container_title Nippon Shokakibyo Gakkai Zasshi
container_volume 85
creator TAKAGI, Hitoshi
YAMADA, Shoji
HAYAKAWA, Kiyoya
OZAWA, Masako
OJIMA, Toru
TAKAYAMA, Hisashi
SAITOH, Shuuichi
UEHARA, Masahiro
ABE, Takehiko
IIZUKA, Harutarou
KATAKAI, Shigeyuki
ICHIKAWA, Kunio
TAKEZAWA, Jirou
NAGAMINE, Takeaki
KOBAYASHI, Setsuo
description We investigated the cases who were positive both HBsAg and anti-HBs in the sera clinically and immunologically. 1) 36 cases in 191 HBsAg positive subjects (18.8%) had anti-HBs in the sera simultaneously, although the anti-HBs of those were not detected by passive hemmaglutination method. 2) In HBs-Ag carriers, the case with chronic liver disease had higher rate of co-occurrence of HBsAg and anti-HBs (27 in 70, 38.6%) than that of asymptomatic carriers (9 in 117, 7.7%, p
doi_str_mv 10.11405/nisshoshi1964.85.186
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78286564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78286564</sourcerecordid><originalsourceid>FETCH-LOGICAL-j244t-93b2ec3777804b28802bf566d8dab45fd07405181eac732a8e5c6614dc636a723</originalsourceid><addsrcrecordid>eNpVUF1LwzAUDaLMMfcTBn3yrTPfSR_nUDcYCKLPIU3TNSNNZtM-7N9b3Bz4ci_n4x64B4AFgkuEKGRPwaXUxNQ4VHC6lGyJJL8BU0RokQtekFswhZTynDPJ78E8JVdCCAtWSEImYEKIZCOYgo-1d8EZ7TMdqsy17RCij_sLo_0puZTFOusbm5mYR2OGrrPB2D9y85xW-99jHXqXj_AB3NXaJzu_7Bn4en35XG_y3fvbdr3a5QdMaZ8XpMTWECGEhLTEUkJc1ozzSla6pKyuoBgfRRJZbQTBWlpmOEe0MpxwLTCZgcdz7rGL34NNvWpdMtZ7HWwckhISS844HY2Li3EoW1upY-da3Z3UpYRR3571Q-r13l513fXOeKv-da0kU_g8xsqvHtPoTtlAfgAUeXtb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78286564</pqid></control><display><type>article</type><title>Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>TAKAGI, Hitoshi ; YAMADA, Shoji ; HAYAKAWA, Kiyoya ; OZAWA, Masako ; OJIMA, Toru ; TAKAYAMA, Hisashi ; SAITOH, Shuuichi ; UEHARA, Masahiro ; ABE, Takehiko ; IIZUKA, Harutarou ; KATAKAI, Shigeyuki ; ICHIKAWA, Kunio ; TAKEZAWA, Jirou ; NAGAMINE, Takeaki ; KOBAYASHI, Setsuo</creator><creatorcontrib>TAKAGI, Hitoshi ; YAMADA, Shoji ; HAYAKAWA, Kiyoya ; OZAWA, Masako ; OJIMA, Toru ; TAKAYAMA, Hisashi ; SAITOH, Shuuichi ; UEHARA, Masahiro ; ABE, Takehiko ; IIZUKA, Harutarou ; KATAKAI, Shigeyuki ; ICHIKAWA, Kunio ; TAKEZAWA, Jirou ; NAGAMINE, Takeaki ; KOBAYASHI, Setsuo</creatorcontrib><description>We investigated the cases who were positive both HBsAg and anti-HBs in the sera clinically and immunologically. 1) 36 cases in 191 HBsAg positive subjects (18.8%) had anti-HBs in the sera simultaneously, although the anti-HBs of those were not detected by passive hemmaglutination method. 2) In HBs-Ag carriers, the case with chronic liver disease had higher rate of co-occurrence of HBsAg and anti-HBs (27 in 70, 38.6%) than that of asymptomatic carriers (9 in 117, 7.7%, p&lt;0.005). 3) In co-occurrent cases, the titer of anti-HBs of chronic liver disease was significantly higher than that of asymptomatic carriers. 4) No differences were obtained from the analysis of the co-occurrent cases and another group about age, sex and the frequency of HBeAg and anti-HBe. 5) There was no differences in non-specific immune complexes between the co-occurent cases and another. HBsAg specific immune complex was detected more in co-occurrent cases than another (p&lt;0.005). The cases with chronic liver disease had more non-specific and HBsAg specific immune complexes than asymptomatic carriers. According to these facts, immune complex seemed to be related to the pathogenesis or the consequences of viral hepatitis and the high incidence of liver disease in co-occurrent cases.</description><identifier>ISSN: 0446-6586</identifier><identifier>EISSN: 1349-7693</identifier><identifier>DOI: 10.11405/nisshoshi1964.85.186</identifier><identifier>PMID: 3385959</identifier><language>jpn</language><publisher>Japan: The Japanese Society of Gastroenterology</publisher><subject>Adult ; Antigen-Antibody Complex - analysis ; Female ; Hepatitis B Antibodies - analysis ; Hepatitis B e Antigens - analysis ; Hepatitis B Surface Antigens - analysis ; Hepatitis B Surface Antigens - immunology ; Humans ; Liver Diseases - immunology ; Male</subject><ispartof>Nippon Shokakibyo Gakkai Zasshi, 1988, Vol.85(2), pp.186-192</ispartof><rights>The Japanese Society of Gastroenterology</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3385959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TAKAGI, Hitoshi</creatorcontrib><creatorcontrib>YAMADA, Shoji</creatorcontrib><creatorcontrib>HAYAKAWA, Kiyoya</creatorcontrib><creatorcontrib>OZAWA, Masako</creatorcontrib><creatorcontrib>OJIMA, Toru</creatorcontrib><creatorcontrib>TAKAYAMA, Hisashi</creatorcontrib><creatorcontrib>SAITOH, Shuuichi</creatorcontrib><creatorcontrib>UEHARA, Masahiro</creatorcontrib><creatorcontrib>ABE, Takehiko</creatorcontrib><creatorcontrib>IIZUKA, Harutarou</creatorcontrib><creatorcontrib>KATAKAI, Shigeyuki</creatorcontrib><creatorcontrib>ICHIKAWA, Kunio</creatorcontrib><creatorcontrib>TAKEZAWA, Jirou</creatorcontrib><creatorcontrib>NAGAMINE, Takeaki</creatorcontrib><creatorcontrib>KOBAYASHI, Setsuo</creatorcontrib><title>Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs</title><title>Nippon Shokakibyo Gakkai Zasshi</title><addtitle>Nippon Shokakibyo Gakkai Zasshi</addtitle><description>We investigated the cases who were positive both HBsAg and anti-HBs in the sera clinically and immunologically. 1) 36 cases in 191 HBsAg positive subjects (18.8%) had anti-HBs in the sera simultaneously, although the anti-HBs of those were not detected by passive hemmaglutination method. 2) In HBs-Ag carriers, the case with chronic liver disease had higher rate of co-occurrence of HBsAg and anti-HBs (27 in 70, 38.6%) than that of asymptomatic carriers (9 in 117, 7.7%, p&lt;0.005). 3) In co-occurrent cases, the titer of anti-HBs of chronic liver disease was significantly higher than that of asymptomatic carriers. 4) No differences were obtained from the analysis of the co-occurrent cases and another group about age, sex and the frequency of HBeAg and anti-HBe. 5) There was no differences in non-specific immune complexes between the co-occurent cases and another. HBsAg specific immune complex was detected more in co-occurrent cases than another (p&lt;0.005). The cases with chronic liver disease had more non-specific and HBsAg specific immune complexes than asymptomatic carriers. According to these facts, immune complex seemed to be related to the pathogenesis or the consequences of viral hepatitis and the high incidence of liver disease in co-occurrent cases.</description><subject>Adult</subject><subject>Antigen-Antibody Complex - analysis</subject><subject>Female</subject><subject>Hepatitis B Antibodies - analysis</subject><subject>Hepatitis B e Antigens - analysis</subject><subject>Hepatitis B Surface Antigens - analysis</subject><subject>Hepatitis B Surface Antigens - immunology</subject><subject>Humans</subject><subject>Liver Diseases - immunology</subject><subject>Male</subject><issn>0446-6586</issn><issn>1349-7693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUF1LwzAUDaLMMfcTBn3yrTPfSR_nUDcYCKLPIU3TNSNNZtM-7N9b3Bz4ci_n4x64B4AFgkuEKGRPwaXUxNQ4VHC6lGyJJL8BU0RokQtekFswhZTynDPJ78E8JVdCCAtWSEImYEKIZCOYgo-1d8EZ7TMdqsy17RCij_sLo_0puZTFOusbm5mYR2OGrrPB2D9y85xW-99jHXqXj_AB3NXaJzu_7Bn4en35XG_y3fvbdr3a5QdMaZ8XpMTWECGEhLTEUkJc1ozzSla6pKyuoBgfRRJZbQTBWlpmOEe0MpxwLTCZgcdz7rGL34NNvWpdMtZ7HWwckhISS844HY2Li3EoW1upY-da3Z3UpYRR3571Q-r13l513fXOeKv-da0kU_g8xsqvHtPoTtlAfgAUeXtb</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>TAKAGI, Hitoshi</creator><creator>YAMADA, Shoji</creator><creator>HAYAKAWA, Kiyoya</creator><creator>OZAWA, Masako</creator><creator>OJIMA, Toru</creator><creator>TAKAYAMA, Hisashi</creator><creator>SAITOH, Shuuichi</creator><creator>UEHARA, Masahiro</creator><creator>ABE, Takehiko</creator><creator>IIZUKA, Harutarou</creator><creator>KATAKAI, Shigeyuki</creator><creator>ICHIKAWA, Kunio</creator><creator>TAKEZAWA, Jirou</creator><creator>NAGAMINE, Takeaki</creator><creator>KOBAYASHI, Setsuo</creator><general>The Japanese Society of Gastroenterology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs</title><author>TAKAGI, Hitoshi ; YAMADA, Shoji ; HAYAKAWA, Kiyoya ; OZAWA, Masako ; OJIMA, Toru ; TAKAYAMA, Hisashi ; SAITOH, Shuuichi ; UEHARA, Masahiro ; ABE, Takehiko ; IIZUKA, Harutarou ; KATAKAI, Shigeyuki ; ICHIKAWA, Kunio ; TAKEZAWA, Jirou ; NAGAMINE, Takeaki ; KOBAYASHI, Setsuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j244t-93b2ec3777804b28802bf566d8dab45fd07405181eac732a8e5c6614dc636a723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Antigen-Antibody Complex - analysis</topic><topic>Female</topic><topic>Hepatitis B Antibodies - analysis</topic><topic>Hepatitis B e Antigens - analysis</topic><topic>Hepatitis B Surface Antigens - analysis</topic><topic>Hepatitis B Surface Antigens - immunology</topic><topic>Humans</topic><topic>Liver Diseases - immunology</topic><topic>Male</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKAGI, Hitoshi</creatorcontrib><creatorcontrib>YAMADA, Shoji</creatorcontrib><creatorcontrib>HAYAKAWA, Kiyoya</creatorcontrib><creatorcontrib>OZAWA, Masako</creatorcontrib><creatorcontrib>OJIMA, Toru</creatorcontrib><creatorcontrib>TAKAYAMA, Hisashi</creatorcontrib><creatorcontrib>SAITOH, Shuuichi</creatorcontrib><creatorcontrib>UEHARA, Masahiro</creatorcontrib><creatorcontrib>ABE, Takehiko</creatorcontrib><creatorcontrib>IIZUKA, Harutarou</creatorcontrib><creatorcontrib>KATAKAI, Shigeyuki</creatorcontrib><creatorcontrib>ICHIKAWA, Kunio</creatorcontrib><creatorcontrib>TAKEZAWA, Jirou</creatorcontrib><creatorcontrib>NAGAMINE, Takeaki</creatorcontrib><creatorcontrib>KOBAYASHI, Setsuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Nippon Shokakibyo Gakkai Zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TAKAGI, Hitoshi</au><au>YAMADA, Shoji</au><au>HAYAKAWA, Kiyoya</au><au>OZAWA, Masako</au><au>OJIMA, Toru</au><au>TAKAYAMA, Hisashi</au><au>SAITOH, Shuuichi</au><au>UEHARA, Masahiro</au><au>ABE, Takehiko</au><au>IIZUKA, Harutarou</au><au>KATAKAI, Shigeyuki</au><au>ICHIKAWA, Kunio</au><au>TAKEZAWA, Jirou</au><au>NAGAMINE, Takeaki</au><au>KOBAYASHI, Setsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs</atitle><jtitle>Nippon Shokakibyo Gakkai Zasshi</jtitle><addtitle>Nippon Shokakibyo Gakkai Zasshi</addtitle><date>1988</date><risdate>1988</risdate><volume>85</volume><issue>2</issue><spage>186</spage><epage>192</epage><pages>186-192</pages><issn>0446-6586</issn><eissn>1349-7693</eissn><abstract>We investigated the cases who were positive both HBsAg and anti-HBs in the sera clinically and immunologically. 1) 36 cases in 191 HBsAg positive subjects (18.8%) had anti-HBs in the sera simultaneously, although the anti-HBs of those were not detected by passive hemmaglutination method. 2) In HBs-Ag carriers, the case with chronic liver disease had higher rate of co-occurrence of HBsAg and anti-HBs (27 in 70, 38.6%) than that of asymptomatic carriers (9 in 117, 7.7%, p&lt;0.005). 3) In co-occurrent cases, the titer of anti-HBs of chronic liver disease was significantly higher than that of asymptomatic carriers. 4) No differences were obtained from the analysis of the co-occurrent cases and another group about age, sex and the frequency of HBeAg and anti-HBe. 5) There was no differences in non-specific immune complexes between the co-occurent cases and another. HBsAg specific immune complex was detected more in co-occurrent cases than another (p&lt;0.005). The cases with chronic liver disease had more non-specific and HBsAg specific immune complexes than asymptomatic carriers. According to these facts, immune complex seemed to be related to the pathogenesis or the consequences of viral hepatitis and the high incidence of liver disease in co-occurrent cases.</abstract><cop>Japan</cop><pub>The Japanese Society of Gastroenterology</pub><pmid>3385959</pmid><doi>10.11405/nisshoshi1964.85.186</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0446-6586
ispartof Nippon Shokakibyo Gakkai Zasshi, 1988, Vol.85(2), pp.186-192
issn 0446-6586
1349-7693
language jpn
recordid cdi_proquest_miscellaneous_78286564
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Antigen-Antibody Complex - analysis
Female
Hepatitis B Antibodies - analysis
Hepatitis B e Antigens - analysis
Hepatitis B Surface Antigens - analysis
Hepatitis B Surface Antigens - immunology
Humans
Liver Diseases - immunology
Male
title Clinical and immunological analysis of the co-occurrence of the HBsAg and anti-HBs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20immunological%20analysis%20of%20the%20co-occurrence%20of%20the%20HBsAg%20and%20anti-HBs&rft.jtitle=Nippon%20Shokakibyo%20Gakkai%20Zasshi&rft.au=TAKAGI,%20Hitoshi&rft.date=1988&rft.volume=85&rft.issue=2&rft.spage=186&rft.epage=192&rft.pages=186-192&rft.issn=0446-6586&rft.eissn=1349-7693&rft_id=info:doi/10.11405/nisshoshi1964.85.186&rft_dat=%3Cproquest_pubme%3E78286564%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78286564&rft_id=info:pmid/3385959&rfr_iscdi=true